Financials

News Discussions Technicals Forecast Seasonals

SYNACT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SYNACT PHARMA AB operating, investing, and financing activities

SYNACT free cash flow for Q3 24 is -24.08 M SEK. For 2023, SYNACT free cash flow was -100.18 M SEK and operating cash flow was -100.18 M SEK.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SEK

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—